Welcome to our dedicated page for Barrick Mining news (Ticker: B), a resource for investors and traders seeking the latest updates and insights on Barrick Mining stock.
Barrick Mining Corporation reports developments tied to its global gold and copper mining, exploration and development portfolio. Company news commonly covers operating and financial results, mine and project updates, technical and governance matters, and capital allocation actions for common shares that trade on the NYSE under B and on the TSX under ABX.
Recurring updates include quarterly results releases, dividend declarations, share repurchase authorizations, annual meeting materials and changes in executive or board oversight. Barrick also reports on its gold assets in North America and other mining jurisdictions, including disclosures connected to major mines, development projects, reserves, production, costs, cash flow and responsible mining obligations.
BioArctic (Nasdaq: B) announces the Nomination Committee's proposals for the Annual General Meeting on May 28, 2026. The committee proposes an eight-member board, re-electing Eugen Steiner as chair and six existing members, and adding Philip Scheltens and Linda Nilsson as new board members.
Pär Gellerfors has declined re-election; Linda Nilsson is proposed to represent the Gellerfors family's holding company. The Nomination Committee members represent ~57% of shares and ~83% of votes.
Hexagon (B) will propose a distribution and listing of Octave Intelligence plc at its AGM on 24 April 2026, where ten Hexagon shares entitle holders to one Octave share. Octave Class B shares are expected to list on Nasdaq New York, with SDRs listed on Nasdaq Stockholm for about two years.
An indicative timetable sets the record date for the distribution on 22 May 2026 and first NY trading on 28 May 2026. Octave will file an amended Form 10 and host an Investor Day on 26 March 2026.
Crawford & Company (NYSE:A) named W. Bruce Swain Jr. president and chief executive officer, effective immediately on March 23, 2026.
Swain served as interim CEO since January 1, 2026, has more than three decades at Crawford including 19 years as CFO, and will remain on the board. Jesse Crawford Sr. will not stand for reelection at the Annual Shareholder Meeting on May 14, 2026, and will become an honorary board member and emeritus officer after the ASM.
BioArctic (NASDAQ: B) reported new data presented at AD/PD 2026 on long-term, real-world IV lecanemab treatment persistence and additional company presentations. Real-world claims analysis showed 78.4% persistence at 18 months, 71.7% at 20 months and 67.3% at 24 months. BioArctic also presented data on lecanemab binding to soluble Aβ protofibrils and a poster on exidavnemab trial screening using alpha-synuclein SAA. The release notes investigational status and no guarantee of regulatory approval.
Cereno Scientific (NASDAQ: B) received Swedish Medical Products Agency approval to start a Phase I pharmacokinetic study of CS014, designed using FDA pre-IND feedback. The open-label, randomized, two-period crossover trial in 14 healthy adults compares seven-day repeat dosing of CS014 versus valproic acid to characterize total and unbound plasma concentrations at steady state.
The company says a successful PK study could remove the need for additional nonclinical safety work and a Phase IIa trial, supporting a capital-efficient path toward a planned Phase II study in PH-ILD in Q1 2027. Results are expected mid-2026.
Contractor Connection (NYSE:A) announced a strategic partnership with Helixco to integrate Helixco’s time-and-materials validation platform into Contractor Connection’s commercial managed repair program. The partnership aims to add real-time transparency, standardized workflows, auditable documentation and improved billing accuracy across commercial repair projects.
The collaboration pairs Helixco’s validation technology with Contractor Connection’s credentialed contractor network to support consistency, accountability and more predictable commercial repair outcomes for carrier partners and contractors.
Hexagon (NYSE:B) released the Robot Generation study across nine markets and 18,000 participants on March 10, 2026. The research finds robot anxiety is highest where robots are least visible (UK 52%) and lowest in high-exposure markets (South Korea 29%). Security is the top worry (51%). The study links visibility, clear purpose, and control to greater public trust and notes strong comfort with robots in factories and for dangerous tasks.
BioArctic (Nasdaq Stockholm: B) issued 78,000 Class B shares in February 2026 under the 2019/2028 stock option program. As of February 27, 2026 the company had 88,719,485 shares: 74,319,489 listed Class B and 14,399,996 unlisted Class A. A shares carry ten votes; B shares carry one vote, giving a total of 218,319,449 votes.
Contact details for investor relations are provided for further inquiries.
Barrick (NYSE:B) announced that its 2025 Annual Report, Annual Information Form and Form 40-F are now available on SEDAR+, EDGAR and Barrick's website.
The company also filed NI 43-101 technical reports for Pueblo Viejo and Kibali gold mines. Shareholders can request audited financial statements free from Investor Relations.
Barrick (NYSE:B) on February 24, 2026 appointed James J. McGuire as Chief Legal and Policy Officer and Woo Lee as Chief Global Affairs Officer. Both will report to CEO Mark Hill and join the Executive Committee. Poupak Bahamin becomes General Counsel and Chief Compliance Officer and remains on the Executive Committee.
McGuire brings over 30 years of legal experience; Lee has over 11 years at Barrick and will lead global government affairs and sovereign relationships.